SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immune responses and infection outcomes were evaluated in 2,686 patients with varying immune-suppressive disease states after administration of two Coronavirus Disease 2019 (COVID-19) vaccines. Overall, 255 of 2,204 (12%) patients failed t...

Full description

Bibliographic Details
Main Authors:	Barnes, E, Goodyear, CS, Willicombe, M, Gaskell, C, Siebert, S, I de Silva, T, Murray, SM, Rea, D, Snowden, JA, Carroll, M, Pirrie, S, Bowden, SJ, Dunachie, SJ, Richter, A, Lim, Z, Satsangi, J, Cook, G, Pope, A, Hughes, A, Harrison, M, Lim, SH, Miller, P, Klenerman, P, Basu, N, Gilmour, A, Irwin, S, Meacham, G, Marjot, T, Dimitriadis, S, Kelleher, P, Prendecki, M, Clarke, C, Mortimer, P, McIntyre, S, Selby, R, Meardon, N, Nguyen, D, Tipton, T, Longet, S, Laidlaw, S, Orchard, K, Ireland, G, Consensus, Thomas, D, Kearns, P, Kirkham, A, McInnes, IB
Other Authors:	PITCH consortium
Format:	Journal article
Language:	English
Published:	Springer Nature 2023

SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease

Similar Items